NCT06601777Active, not recruiting
Evaluation of the Effectiveness, Safety, and Cost of a Smart Hospital System for Patients With Chronic Obstructive Pulmonary Disease
Evaluation of the Effectiveness, Safety, and Cost of a Smart Hospital System for Patients With Chronic Obstructive Pulmonary Disease: Prospective Multicenter Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 13 Jul 2026
Brief summary (registry, in English)
This study aims to analyze the effectiveness/safety/cost of the Smart Homespital system that provides a service that allows patients with Chronic Obstructive Pulmonary Disease to easily access and use biosignals generated using biosignal collection medical equipment at home.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 196 (actual)
- First submitted
- 8 Sept 2024
- Start date
- 11 Sept 2024
- Primary completion date
- 6 Aug 2026
- Lead sponsor
- Yonsei University
- Diseases
- COPD
- NCT number
- NCT06601777
What you commit to
- Study type: Interventional
- Participants enrolled: 196
- From 11 Sept 2024 to the primary completion date, 6 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving hospital-centered rehabilitation treatment during the study period.
Other
- Patients who do not agree to participate in the study.
- Patients who fail to use the medical device equipment.
- Patients where tracking during the study period is expected to be impossible.
- Patients who have difficulty communicating verbally.
- Patients who are bedridden or unable to exercise at all due to severe cardiorespiratory dysfunction.
Who the study is looking for
- Patients diagnosed with COPD who meet the following pulmonary function test results:
- Pre FEV1 \< 80% \*\*or\*\*
- Pre FVC \< 80% \*\*or\*\*
- DLCO \< 60%
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Severance hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.